期刊文献+

nm23基因在原发性乳腺癌组织中的表达及临床意义

下载PDF
导出
摘要 目的:研究原发性乳腺癌组织中 nm23的表达及临床意义。方法:采用 SP 法检测497例原发性乳腺癌nm23基因的表达情况及与临床、病理诸因素之间的关系,并分析其表达间的相关性。结果:(1)原发性乳腺癌中nm23阳性率为67.2%;(2)nm23与淋巴结转移、肿瘤大小、临床分期有相关性。结论:(1)原发性乳腺癌中 nm23的表达与肿瘤的浸润、转移密切相关。(2)在临床中对 nm23进行检测,有助于判断乳腺癌,尤其是腋淋巴结阴性乳腺癌的恶性程度和生物学行为,协助制定术后治疗方案。(3)nm23是乳腺癌预后的重要预测指标。该基因表达的检测作为乳腺癌常规病理检查,可用于判断乳腺癌的预后及拟定术后治疗方案。
出处 《新疆医学》 2007年第6期20-22,共3页 Xinjiang Medical Journal
  • 相关文献

参考文献10

  • 1Steeg PS,Bevilacqua G,Kopper L,et al.Evidence for a novel gene associated with lowtumor metastatic potential.J Natl Cancer Inst,1988,80(3):200-204.
  • 2刘红,毛慧生,傅西林,方志沂,冯玉梅,范宇,李树玲.nm23基因表达与乳腺癌远处转移及预后相关性的研究[J].中华肿瘤杂志,2001,23(3):224-227. 被引量:32
  • 3Belev B,Aleric I,Vrbanec D,et al.nm23 gene product expression in invasive breast cancer-immunohistochemical analysis and clinicopathological correlation.Acta Oncol,2002,41(4):355-361.
  • 4Gohring UJ,Eustermann I,Becker M,etal.Lack Of prognostic significance of nm23 expression in human primary breast cancer.OncolRep,2002,9 (6):1205-1208.
  • 5周正平,刘华庆.乳腺癌组织中nm23、c-erbB-2、p53表达与临床病理特征的关系[J].实用癌症杂志,2003,18(4):359-361. 被引量:17
  • 6Hlupic L,Jakic-Razumovic J,Bozikov J,etal,Prognostic alue Of different factors in breast carcinoma.Tumor,2004,90(1):112-119.
  • 7王玉杰,郭文斌,姜清华.乳腺癌腋淋巴结微小转移灶与nm23基因表达的研究[J].中国普通外科杂志,2003,12(5):351-353. 被引量:7
  • 8Freije JM,Macdonald NJ,Steey PS.NM23 and tumour metastasis:basic and translational advances.Biochem Soc Symp,2004,63(1):261-271.
  • 9Leone A,Flatow U,King CR,et al.Reduced tumor incidence,metastatic potential,andcytokine responsiveness of nm23-transfected melanoma cells.Cell,2005,65; 25-35.
  • 10李树玲.乳腺癌防治研究现状[J].国外医学(肿瘤学分册),1993,20(4):221-226. 被引量:28

二级参考文献19

  • 1张声,叶圣华,林华.p53过表达和nm23低表达与胃癌淋巴结转移关系的探讨[J].中华肿瘤杂志,1995,17(6):418-421. 被引量:30
  • 2陈朝伦,卢晓梅,黄绒,黎音,古丽娜尔,沈宝茵,A J Cochran,D R Wen,W F Coulson.Ⅰ期癌症患者切除淋巴结内隐匿性微小转移癌灶的检查及其临床病理意义[J].中华肿瘤杂志,1997,19(1):69-71. 被引量:16
  • 3Richard J,Cote MD,Paul P,et al.Monoelonal antibodies detect occlut breast carcinoma metastasis in the bone marrow of patients with early stage disease [J].Am J SurPathol, 1988,12 (5) : 333- 340.
  • 4Cote R J, Rosen PP, Lesser ML, et al.Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases[J]. J Clin Onco1,1991,9(10) : 1749-1756.
  • 5Ronald A,Ghossein MD,Juan Rosai MD.Polymerase chain reaction in detection of micrometastases and circulating tumor cells[J]. Cancer, 1996, 78(1):10-16.
  • 6Steeg PS, Bevilacgua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential[J] .J Natl Cancer Inst,1988,80(3):200.
  • 7Hennessy C, Henry JA, May FE,et al. Expression of the antimetastatic geng nm23 in human breast cancer:An association with good prognosis[J]. J Natl Cancer Lust,1991,83(4) :281.
  • 8Michael PD. Clinical significance of HER-2/neu overexpression : Part I [M]. Principles & Practice of Oncology,1999,13(1) :1.
  • 9Velculescu VE, EL-Deity WS. Biological and clinical importance of the p53 tumor suppressor gene [J]. Clin Chem, 1996,42(6) :858.
  • 10Steeg PS,Bevilacqua G,Kopper L,et al.Evidence for a novel gene associated with low tumor metastatic potential[].Journal of the National Cancer Institute.1988

共引文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部